Overview
Heart neoplasms are rare, predominantly benign, with hamartomas being an uncommon subtype composed of mature cardiac myocytes, fibroblasts, adipocytes, and blood vessels 1.Diagnosis
Imaging Techniques: Magnetic Resonance Imaging (MRI) is crucial for tissue characterization and tumor delineation 23.
MRI Findings: Useful for distinguishing between myxoma, angiosarcoma, mesothelioma, fibroma, and lymphoma through T1-, T2-weighted images, and gadolinium enhancement 23.
Echocardiography: Often used in conjunction with MRI for initial tumor detection and assessment of cardiac structures 23.
Histological Confirmation: Essential for definitive diagnosis, particularly for ruling out other tumors like rhabdomyoma and myxoma 1.
Immunohistochemistry: Can aid in identifying specific cell types within the tumor, e.g., desmin, muscle-specific actin, and CD34 markers 1.Management
Surgical Excision: Primary treatment for most benign and many malignant heart tumors, tailored to tumor type and location 12.
Medical Management: Limited specific drug treatments mentioned; supportive care and management of complications may be necessary 12.
MRI Monitoring: Post-treatment surveillance using MRI to assess recurrence and tumor margins 23.Special Populations
Pediatrics: Rhabdomyomas are more common in pediatric populations, often associated with tuberous sclerosis 2.
Comorbidities: No specific management adjustments noted for comorbidities; individualized care based on patient status is recommended 12.Key Recommendations
Utilize MRI for comprehensive evaluation of heart neoplasms, including tissue characterization and tumor localization (Evidence: Strong 23).
Confirm diagnosis histologically, employing immunohistochemistry when necessary to differentiate between tumor types (Evidence: Moderate 1).
Employ surgical excision as the primary treatment modality for most heart neoplasms, guided by imaging findings (Evidence: Expert opinion 12).References
1 Mantilla-Hernández JC, Amaya-Mujica J, Alvarez-Ojeda OM. An unusual tumour: Hamartoma of mature cardiac myocytes. Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 2019. link
2 Kaminaga T, Takeshita T, Kimura I. Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. European radiology 2003. link
3 Kaminaga T, Takeshita T, Kimura I. Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. European radiology 2003. link